Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669889 · ClinicalTrials.gov registry record
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A clinical trial, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 38
- Enrollment target
NCT01669889 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 38 participants.
The verdict
NCT01669889 has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This multi-center, non-drug study will explore the relationship between exploratory biomarkers and functional dimensions in male adult individuals with Autistic Disorder or Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of assessments on study visit Day 1.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669889
The ClinicalTrials.gov registry entry for NCT01669889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01669889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669889 about?
NCT01669889 is a clinical study titled "A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome". This multi-center, non-drug study will explore the relationship between exploratory biomarkers and functional dimensions in male adult individuals with Autistic Disorder or Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of assessments on study visit Day 1.
What is the current status of trial NCT01669889?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2013-01. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01669889?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.